Investigating the effectiveness of probiotics in the treatment of jaundice in Lightweight newborns

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250103064264N1

Enrollment

Registered

2025-05-27

Start date

2025-06-26

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Jaundice in newborns. Neonatal jaundice from other specified causes

Interventions

Intervention 1: Low birth weight neonate with jaundice who were given probiotics in addition to standard treatments in this study. Intervention 2: Low birth weight neonate with jaundice who were given

Eligibility

Sex/Gender

All

Age

2 Days to 30 Days

Inclusion criteria

Inclusion criteria: birth weight less than 2.5 kg and more than 1 kg age less than 30 days

Exclusion criteria

Exclusion criteria: Having Infectious diseases Having heart diseases Suffering from digestive diseases Suffering from kidney diseases Having respiratory diseases that require a ventilator Congenital anomalies Jaundice due to hemolysis

Design outcomes

Primary

Measure	Time frame
Reducing the number of days needed for phototherapy. Timepoint: 24, 48, and 72 hours after the start of taking probiotics or placebo. Method of measurement: Bilirubin measurement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAhmad shah Farhat

Mashhad University of Medical Sciences

FarhatA@mums.ac.ir+98 51 3854 3031

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026